We found no difference in radiosensitivity between the nine patients without the drug versus the four patients using the drug (p = 0.911), indicating that the mTOR inhibitor probably did not affect radiosensitivity in TSC patients in this study. Here, MTOR is linked to tuberous sclerosis.